iRhythm Technologies (NASDAQ:IRTC) Stock Gets Price Target Trim from Truist Financial

Posted by Stanley Muller on Nov 12th, 2026

iRhythm Technologies (NASDAQ:IRTC – Free Report) had its target price lowered by Truist Financial from $168.00 to $140.00 in a research note issued to investors on Monday morning,Benzinga reports. The firm currently has a buy rating on the stock.

A number of other analysts also recently weighed in on the company. Citigroup downgraded iRhythm Technologies from a “buy” rating to a “neutral” rating and cut their target price for the company from $157.00 to $124.00 in a research report on Friday, November 6th. Wells Fargo & Company reduced their target price on iRhythm Technologies from $150.00 to $135.00 and set an “overweight” rating on the stock in a report on Friday, November 6th. Needham & Company LLC decreased their price target on iRhythm Technologies from $194.00 to $165.00 and set a “buy” rating on the stock in a research report on Friday, November 6th. Wall Street Zen downgraded iRhythm Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, October 10th. Finally, BTIG Research dropped their price target on iRhythm Technologies from $185.00 to $170.00 and set a “buy” rating for the company in a research note on Friday, November 6th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $164.07.

Read Our Latest Analysis on IRTC

iRhythm Technologies Stock Up 3.0%

Shares of IRTC opened at $88.68 on Monday. The company has a current ratio of 3.57, a quick ratio of 3.45 and a debt-to-equity ratio of 3.68. iRhythm Technologies has a 12 month low of $82.85 and a 12 month high of $192.47. The firm’s 50 day moving average is $112.99 and its 200-day moving average is $120.57. The stock has a market capitalization of $2.98 billion, a PE ratio of 64.22 and a beta of 1.39.

iRhythm Technologies (NASDAQ:IRTC – Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.80. The business had revenue of $221.59 million during the quarter, compared to analysts’ expectations of $222.23 million. iRhythm Technologies had a positive return on equity of 26.88% and a negative net margin of 4.52%. The firm’s revenue for the quarter was up 14.9% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.06) earnings per share. Equities research analysts forecast that iRhythm Technologies will post 0.79 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Rothschild Investment LLC boosted its holdings in shares of iRhythm Technologies by 170.0% in the 3rd quarter. Rothschild Investment LLC now owns 216 shares of the company’s stock valued at $25,000 after purchasing an additional 136 shares in the last quarter. Versant Capital Management Inc increased its stake in shares of iRhythm Technologies by 123.2% in the 3rd quarter. Versant Capital Management Inc now owns 221 shares of the company’s stock valued at $25,000 after purchasing an additional 122 shares during the last quarter. Global Retirement Partners LLC raised its holdings in shares of iRhythm Technologies by 5,450.0% during the 3rd quarter. Global Retirement Partners LLC now owns 222 shares of the company’s stock worth $25,000 after buying an additional 218 shares in the last quarter. Covestor Ltd raised its holdings in shares of iRhythm Technologies by 44.8% during the 3rd quarter. Covestor Ltd now owns 417 shares of the company’s stock worth $47,000 after buying an additional 129 shares in the last quarter. Finally, Harbor Investment Advisory LLC acquired a new position in shares of iRhythm Technologies during the 2nd quarter worth $50,000.

About iRhythm Technologies

(Get Free Report)

iRhythm Technologies is a medical technology company that develops digital solutions for detecting and monitoring heart rhythm disorders. Its services combine wearable electrocardiogram (ECG) devices with cloud-based data analysis and clinical reporting to help healthcare professionals assess patients for conditions such as cardiac arrhythmias. The company’s Zio product line includes wearable ECG monitors, such as Zio XT, which records a patient’s heart activity during an extended monitoring period. iRhythm also offers Zio AT, a monitoring service designed to provide clinicians with ECG data during the monitoring period.